The prognosis of prostate cancer is mainly determined by the presence or ab
sence of metastases. Nevertheless, the metastatic pathways in prostate canc
er are not entirely understood. Among 19,316 routine autopsies performed fr
om 1967 to 1995 on men older than 40 years of age, the reports from those 1
,589 (8.2%) with prostate cancer were analyzed. Hematogeneous metastases we
re present in 35% of 1,589 patients with prostate cancer, with most frequen
t involvement being bone (90%), lung (46%), liver (25%), pleura (21%), and
adrenals (13%). Several lines of evidence suggested the existence of a back
ward metastatic pathway through veins from the prostate to the spine in add
ition to classical hematogeneous tumor spread via the vena cava. First, the
re was an inverse relationship between spine and lung metastases, suggestin
g that metastasis to the spine is independent of lung metastasis. Second, t
he maximum frequency of spine involvement occurred in smaller tumors (4 to
6 cm) as compared with the maximum spread to lung (6 to 8 cm) and liver (>8
cm), suggesting that spine metastases precede lung and liver metastases in
many prostate cancers. Third, there was a gradual decrease in spine involv
ement from the lumbar to the cervical level (97% v 38%), which is consisten
t with a subsequent upward metastatic spread along spinal veins after initi
al lumbar metastasis. The results of this study show that bone, lung, and l
iver are the most frequent sites of distant prostate cancer metastases, Bes
ides the cava-type of metastasis through lung passage, there are strong arg
uments for the existence and clinical significance of a backward venous spr
ead to the spine, which is likely to occur early in the metastatic process.
Copyright (C) 2000 by W.B. Saunders Company.